COLLEGIUM PHARMACEUTICAL, INC
COLLDrugs in Pipeline
1
Phase 3 Programs
1
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 1 past
No catalysts found.
How COLL's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
Oxycodone DETERx | Phase 3 | Chronic Low Back Pain | - | - |
Frequently asked questions
What is in COLLEGIUM PHARMACEUTICAL, INC's drug pipeline?→
CatalystAlert tracks 1 drug candidate in COLLEGIUM PHARMACEUTICAL, INC's (COLL) pipeline across Phase 3. Its lead program is Oxycodone DETERx (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is COLLEGIUM PHARMACEUTICAL, INC's next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for COLLEGIUM PHARMACEUTICAL, INC (COLL) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track COLL biotech catalysts?→
Add COLL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow COLLEGIUM PHARMACEUTICAL, INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.